アグマチンの2030年までの市場予測：形状、販売チャネル、用途、地域別の世界分析

Stratistics MRCによると、世界のアグマチン市場は2023年に5,970万米ドルを占め、2030年には1億2,160万米ドルに達する見込みで、予測期間中のCAGRは10.7%です。

アグマチン市場とは、アミノ酸アルギニン由来の化合物である硫酸アグマチンの世界の取引と消費を指します。アグマチンは、運動能力の向上、疼痛管理、認知機能のサポートなど、その潜在的な健康効果で注目を集めています。神経保護作用が期待されることから、神経障害性疼痛やうつ病などの神経疾患の治療薬として有望視されています。

世界保健機関（WHO）によると、慢性疾患は世界全体の死亡原因の74％に相当する約4,100万人が毎年死亡しており、このうち約1,700万人が70歳以前に死亡しています。

スポーツとフィットネス活動の人気

スポーツとフィットネス活動の人気は、運動能力と回復を高めるというアグマチンの利点が認識されているため、アグマチン市場の促進要因となっています。アスリートやフィットネス愛好家は、トレーニングレジメンを最適化し、身体能力を向上させる方法を絶えず模索しており、アグマチンのようなサプリメントに対する需要の高まりにつながっています。アグマチンは、一酸化窒素の産生を増加させ、血流を改善し、持久力と筋ポンプを強化する能力があるとされているため、この層にとっては特に魅力的です。さらに、フィットネスの目標達成と全体的な健康の維持にますます重点を置くようになるにつれて、栄養補助食品を日課に取り入れる傾向が強まり、アグマチン製品の需要をさらに押し上げています。

価格感度

アグマチンは、他の栄養補助食品と比べて割高な価格で販売されることが多いため、価格に敏感な消費者が定期的に購入するのをためらう可能性があります。このような価格力学は、特にヘルスケア支出において費用対効果を優先する消費者の間で、市場の成長可能性を制限する可能性があります。同様の効能を持つ代替品が低価格で入手可能な市場では、アグマチン製品の普及に苦戦する可能性があります。しかし、アグマチン市場のメーカーやマーケティング担当者は、製品の品質や効能と手頃な価格とのバランスをとり、より幅広い消費者層にアピールするという課題に直面しています。

予防ヘルスケアへの注目

病気を予防し長寿を促進するために最適な健康状態を維持することの重要性に対する認識が高まるにつれ、基本的な栄養摂取を超えた健康上のメリットが期待できるアグマチンのようなサプリメントへの関心が高まっています。アグマチンの神経保護作用は、心臓血管の健康維持、疼痛管理、認知機能強化といった役割とともに、予防ヘルスケアの目標に合致しています。全体的な健康を増進し、慢性疾患のリスクを軽減する方法を模索する中で、ヘルスケアを補完するアプローチとして栄養補助食品が注目されています。

限られた臨床エビデンス

予備的な調査では、神経保護、疼痛管理、認知機能向上など、健康への潜在的な効果が示唆されているもの、しっかりとした臨床試験や包括的な研究が行われていないため、その有効性や安全性については不確かなままです。十分な科学的検証がなされない限り、消費者、ヘルスケア専門家、規制機関は、アグマチン製品の推奨や承認に慎重な姿勢を崩さず、市場の成長が制限される可能性があります。しかし、決定的な証拠がないため、潜在的な消費者が懐疑的になり、アグマチン・サプリメントへの投資を思いとどまる可能性もあります。

COVID-19の影響：

消費者の健康意識が高まり、免疫力を高めることに重点を置くようになったため、アグマチンを含む栄養補助食品に対する需要が急増しています。この動向は、全体的な健康の維持とウイルスに対する回復力に対する懸念によってもたらされています。パンデミックはまた、世界のサプライチェーンと製造オペレーションを混乱させ、原材料の調達と最終製品の製造に課題をもたらしました。しかし、経済の不確実性や消費者の消費パターンの変化は購買行動に影響を及ぼしており、栄養補助食品のような裁量的な買い物よりも必需品を優先する個人も出てきています。

予測期間中、パウダー・セグメントが最大となる見込み

粉末分野は、消費者が飲料に混ぜたりレシピに取り入れたりしやすく、多様な嗜好やライフスタイルに対応できる利便性と汎用性を備えているため、予測期間中に市場で最大のシェアを占めると予測されます。このような使い勝手の良さは、特に栄養補助食品を毎日のルーチンに組み込むシンプルでカスタマイズ可能な方法を求める個人の間で、アグマチン製品の魅力を高めています。さらに、粉末製剤は他の形態に比べて1回分あたりのアグマチンの濃度が高いことが多く、コストパフォーマンスに優れ、コスト意識の高い消費者を惹きつける可能性があります。

予測期間中にCAGRが最も高くなると予想されるのはドラッグストア部門です。

ドラッグストア部門は、支配期間を通じて収益性の高い成長を維持すると考えられます。アグマチンは、痛みの緩和、気分の向上、認知機能の改善など、その潜在的な健康効果がこのセグメントで認知されるにつれて、自然な代替品を求める消費者にますます求められるようになります。ドラッグストアは、その広範な存在感と消費者の信頼を利用して、アグマチン製品を積極的に在庫し、販売促進を行い、需要を牽引しています。

最もシェアの高い地域：

良好な規制基準、栄養補助食品および栄養成分に関する法律の改正による使用と消費の促進、神経保護および気分向上特性に関する製品の潜在的可能性を調べることの重視の高まりにより、アジア太平洋地域が予測期間中最大のシェアを占めると予想されます。これらの特性が増加している地域におけるアグマチンを含む製品の需要は、GDP成長率、可処分所得の水準、消費者の購買パターンなどの経済的要因によって影響を受ける可能性があります。

CAGRが最も高い地域：

アジア太平洋地域は、予測期間中に有利な成長を遂げると予想されます。規制機関は、医薬品、栄養補助食品、農業におけるアグマチンの安全性と有効性を認めつつあり、これはメーカーと消費者の信頼感を高めています。承認プロセスが合理化され、アグマチンの使用に関するガイドラインが明確化されたことで、アグマチンの製品への配合が容易になり、この地域の市場成長が促進されています。さらに、同地域における研究と技術革新の促進を目的とした支援政策により、アグマチン関連の研究開発活動への投資が促進され、新たな用途や製造方法の開発につながっています。

無料のカスタマイズ提供：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査資料
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 用途分析
• 新興市場
• COVID-19の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界のアグマチン市場：形状別

• カプセル
• 粉

第6章 世界のアグマチン市場：販売チャネル別

• 専門店
• ドラッグストア
• 健康・美容店
• サードパーティのオンラインチャネル
• その他の販売チャネル

第7章 世界のアグマチン市場：用途別

• サプリメントと栄養補助食品
• 製薬
• その他の用途

第8章 世界のアグマチン市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第9章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイリング

• Ajinomoto Co., Inc
• Douglas Laboratories
• Dymatize Nutrition
• Glanbia Nutritionals
• Jarrow Formulas
• Metabolic Maintenance
• NOW Foods Inc
• Nutrabio Inc
• Prinova Group LLC
• Swanson Health

List of Tables

• Table 1 Global Agmatine Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Agmatine Market Outlook, By Form (2021-2030) ($MN)
• Table 3 Global Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
• Table 4 Global Agmatine Market Outlook, By Powder (2021-2030) ($MN)
• Table 5 Global Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
• Table 6 Global Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
• Table 7 Global Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
• Table 8 Global Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
• Table 9 Global Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
• Table 10 Global Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
• Table 11 Global Agmatine Market Outlook, By Application (2021-2030) ($MN)
• Table 12 Global Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
• Table 13 Global Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
• Table 14 Global Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 15 North America Agmatine Market Outlook, By Country (2021-2030) ($MN)
• Table 16 North America Agmatine Market Outlook, By Form (2021-2030) ($MN)
• Table 17 North America Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
• Table 18 North America Agmatine Market Outlook, By Powder (2021-2030) ($MN)
• Table 19 North America Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
• Table 20 North America Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
• Table 21 North America Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
• Table 22 North America Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
• Table 23 North America Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
• Table 24 North America Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
• Table 25 North America Agmatine Market Outlook, By Application (2021-2030) ($MN)
• Table 26 North America Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
• Table 27 North America Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
• Table 28 North America Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 29 Europe Agmatine Market Outlook, By Country (2021-2030) ($MN)
• Table 30 Europe Agmatine Market Outlook, By Form (2021-2030) ($MN)
• Table 31 Europe Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
• Table 32 Europe Agmatine Market Outlook, By Powder (2021-2030) ($MN)
• Table 33 Europe Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
• Table 34 Europe Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
• Table 35 Europe Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
• Table 36 Europe Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
• Table 37 Europe Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
• Table 38 Europe Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
• Table 39 Europe Agmatine Market Outlook, By Application (2021-2030) ($MN)
• Table 40 Europe Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
• Table 41 Europe Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
• Table 42 Europe Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 43 Asia Pacific Agmatine Market Outlook, By Country (2021-2030) ($MN)
• Table 44 Asia Pacific Agmatine Market Outlook, By Form (2021-2030) ($MN)
• Table 45 Asia Pacific Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
• Table 46 Asia Pacific Agmatine Market Outlook, By Powder (2021-2030) ($MN)
• Table 47 Asia Pacific Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
• Table 48 Asia Pacific Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
• Table 49 Asia Pacific Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
• Table 50 Asia Pacific Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
• Table 51 Asia Pacific Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
• Table 52 Asia Pacific Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
• Table 53 Asia Pacific Agmatine Market Outlook, By Application (2021-2030) ($MN)
• Table 54 Asia Pacific Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
• Table 55 Asia Pacific Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
• Table 56 Asia Pacific Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 57 South America Agmatine Market Outlook, By Country (2021-2030) ($MN)
• Table 58 South America Agmatine Market Outlook, By Form (2021-2030) ($MN)
• Table 59 South America Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
• Table 60 South America Agmatine Market Outlook, By Powder (2021-2030) ($MN)
• Table 61 South America Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
• Table 62 South America Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
• Table 63 South America Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
• Table 64 South America Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
• Table 65 South America Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
• Table 66 South America Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
• Table 67 South America Agmatine Market Outlook, By Application (2021-2030) ($MN)
• Table 68 South America Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
• Table 69 South America Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
• Table 70 South America Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 71 Middle East & Africa Agmatine Market Outlook, By Country (2021-2030) ($MN)
• Table 72 Middle East & Africa Agmatine Market Outlook, By Form (2021-2030) ($MN)
• Table 73 Middle East & Africa Agmatine Market Outlook, By Capsules (2021-2030) ($MN)
• Table 74 Middle East & Africa Agmatine Market Outlook, By Powder (2021-2030) ($MN)
• Table 75 Middle East & Africa Agmatine Market Outlook, By Sales Channel (2021-2030) ($MN)
• Table 76 Middle East & Africa Agmatine Market Outlook, By Specialty Stores (2021-2030) ($MN)
• Table 77 Middle East & Africa Agmatine Market Outlook, By Drug Stores (2021-2030) ($MN)
• Table 78 Middle East & Africa Agmatine Market Outlook, By Health & Beauty Stores (2021-2030) ($MN)
• Table 79 Middle East & Africa Agmatine Market Outlook, By Third-party Online Channels (2021-2030) ($MN)
• Table 80 Middle East & Africa Agmatine Market Outlook, By Other Sales Channels (2021-2030) ($MN)
• Table 81 Middle East & Africa Agmatine Market Outlook, By Application (2021-2030) ($MN)
• Table 82 Middle East & Africa Agmatine Market Outlook, By Supplements & Neutraceuticals (2021-2030) ($MN)
• Table 83 Middle East & Africa Agmatine Market Outlook, By Pharmaceutical (2021-2030) ($MN)
• Table 84 Middle East & Africa Agmatine Market Outlook, By Other Applications (2021-2030) ($MN)

According to Stratistics MRC, the Global Agmatine Market is accounted for $59.7 million in 2023 and is expected to reach $121.6 million by 2030 growing at a CAGR of 10.7% during the forecast period. The agmatine market refers to the global trade and consumption of agmatine sulfate, a compound derived from the amino acid arginine. Agmatine has gained attention for its potential health benefits, including its role in enhancing athletic performance, managing pain, and supporting cognitive function. It is utilized for its potential neuroprotective properties, making it a promising candidate for the treatment of neurological disorders like neuropathic pain and depression.

According to the World Health Organization, chronic diseases are the major cause of death globally with around 41 million deaths each year equivalent to 74% of total deaths globally, and around 17 million out of these deaths take place before age 70.

Market Dynamics:

Driver:

Popularity of sports and fitness activities

The popularity of sports and fitness activities serves as a driver of the agmatine market due to the compound's perceived benefits in enhancing athletic performance and recovery. Athletes and fitness enthusiasts are continually seeking ways to optimize their training regimens and improve their physical capabilities, leading to a growing demand for supplements like agmatine. Agmatine's purported ability to increase nitric oxide production, improve blood flow, and enhance endurance and muscle pump makes it particularly attractive to this demographic. Moreover, as individuals become increasingly focused on achieving their fitness goals and maintaining overall well-being, they are more inclined to incorporate nutritional supplements into their routines, further propelling the demand for agmatine products.

Restraint:

Price sensitivity

Agmatine often come at a premium price compared to other nutritional products, which can deter price-conscious consumers from purchasing them regularly. This pricing dynamic may limit the market's growth potential, especially among individuals who prioritize cost-effectiveness in their healthcare spending. In markets where alternatives offering similar benefits are available at lower prices, agmatine products may struggle to gain traction. However, manufacturers and marketers in the agmatine market face the challenge of balancing product quality and efficacy with affordability to appeal to a broader consumer base.

Opportunity:

Focus on preventive healthcare

With rising awareness of the importance of maintaining optimal health to prevent diseases and promote longevity, there's a growing interest in supplements like agmatine that offer potential health benefits beyond basic nutrition. Agmatine's purported neuroprotective properties, along with its role in supporting cardiovascular health, managing pain, and enhancing cognitive function, align well with the goals of preventive healthcare. As individuals seek ways to enhance their overall well-being and reduce the risk of chronic conditions, they are turning to dietary supplements as a complementary approach to their healthcare regimen.

Threat:

Limited clinical evidence

While preliminary research suggests potential health benefits, including neuroprotection, pain management, and cognitive enhancement, the lack of robust clinical trials and comprehensive studies leaves uncertainties regarding its efficacy and safety. Without sufficient scientific validation, consumers, healthcare professionals, and regulatory bodies may remain cautious about recommending or approving agmatine products, limiting market growth. However, the absence of conclusive evidence may lead to skepticism among potential consumers, deterring them from investing in agmatine supplements.

Covid-19 Impact:

There has been a surge in demand for dietary supplements, including agmatine, as consumers have become increasingly health-conscious and focused on boosting their immunity. This trend has been driven by concerns about maintaining overall wellness and resilience against the virus. The pandemic has also disrupted global supply chains and manufacturing operations, leading to challenges in sourcing raw materials and producing finished products. However, economic uncertainties and changes in consumer spending patterns have influenced purchasing behaviors, with some individuals prioritizing essential goods over discretionary purchases like dietary supplements.

The powder segment is expected to be the largest during the forecast period

Powder segment is prophesied to witness the largest share of the market during the overcast period as it offers convenience and versatility, allowing consumers to easily mix them into beverages or incorporate them into recipes, catering to diverse preferences and lifestyles. This ease of use enhances the appeal of agmatine products, particularly among individuals seeking simple and customizable ways to integrate nutritional supplements into their daily routines. Additionally, powdered formulations often provide higher concentrations of agmatine per serving compared to other formats, offering better value for money and potentially attracting cost-conscious consumers.

The drug stores segment is expected to have the highest CAGR during the forecast period

Drug Stores segment is positioned to hold profitable growth throughout the domination period. As agmatine gains recognition in this segment for its potential health benefits, such as pain relief, mood enhancement, and cognitive improvement, it becomes increasingly sought after by consumers looking for natural alternatives. Drug stores, leveraging their widespread presence and consumer trust, actively stock and promote agmatine products, thereby driving demand.

Region with largest share:

Due to favorable regulatory standards, changes in laws pertaining to dietary supplements and nutritional ingredients that promote their use and consumption, and a growing emphasis on examining the product's potential for neuroprotective and mood-enhancing properties, the Asia-Pacific region is anticipated to hold the largest share during the projection period. The demand for products containing agmatine in the region where these characteristics are increasing can be influenced by economic factors such as GDP growth, levels of disposable income, and consumer purchasing patterns.

Region with highest CAGR:

Asia Pacific is expected to witness lucrative growth over the extrapolated period. Regulatory bodies are increasingly acknowledging the safety and efficacy of agmatine in pharmaceuticals, dietary supplements, and agriculture, which is instilling confidence among manufacturers and consumers alike. Streamlined approval processes and clear guidelines regarding the use of agmatine are facilitating its incorporation into products, thereby driving market growth in the region. Additionally, supportive policies aimed at promoting research and innovation in the region is encouraging investment in R&D activities related to agmatine, leading to the development of new applications and production methods.

Key players in the market

Some of the key players in Agmatine market include Ajinomoto Co., Inc, Douglas Laboratories, Dymatize Nutrition, Glanbia Nutritionals, Jarrow Formulas, Metabolic Maintenance, NOW Foods Inc, Nutrabio Inc, Prinova Group LLC and Swanson Health.

Key Developments:

In August 2023, Hi-Tech Pharmaceuticals, unveiled its new KRANK3D pre-workout supplement, that utilizes the novel approach called Arginase Inhibition. It is mainly designed to accelerate muscle growth through creating a feeding pool flourishing with compounds.

In April 2023, Bucked Up, a leading sports nutrition and lifestyle brand, announced the launch of a first-of-its-kind pre-workout product called Pixie Pump. The newly developed product includes agmatine, nitrosigine, Vitamin B6, Vitamin B12, and Himalayan rock salt, and is free from caffeine.

In January 2022, Dr. Riggs Rhelief, introduced its new revolutionary functional herbal beverage powder, which offers significant pain relief within just a few minutes and is also quickly absorbed into the bloodstream. The newly launched beverage contains the amino acid arginine, which is metabolized into agmatine and ornithine, resulting in less nerve pain.

Forms Covered:

• Capsules
• Powder

Sales Channels Covered:

• Specialty Stores
• Drug Stores
• Health & Beauty Stores
• Third-party Online Channels
• Other Sales Channels

Applications Covered:

• Supplements & Nutraceuticals
• Pharmaceutical
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Agmatine Market, By Form

• 5.1 Introduction
• 5.2 Capsules
• 5.3 Powder

6 Global Agmatine Market, By Sales Channel

• 6.1 Introduction
• 6.2 Specialty Stores
• 6.3 Drug Stores
• 6.4 Health & Beauty Stores
• 6.5 Third-party Online Channels
• 6.6 Other Sales Channels

7 Global Agmatine Market, By Application

• 7.1 Introduction
• 7.2 Supplements & Neutraceuticals
• 7.3 Pharmaceutical
• 7.4 Other Applications

8 Global Agmatine Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Ajinomoto Co., Inc
• 10.2 Douglas Laboratories
• 10.3 Dymatize Nutrition
• 10.4 Glanbia Nutritionals
• 10.5 Jarrow Formulas
• 10.6 Metabolic Maintenance
• 10.7 NOW Foods Inc
• 10.8 Nutrabio Inc
• 10.9 Prinova Group LLC
• 10.10 Swanson Health